stars 1 stars 2 stars 3

EriVan Bio is a biotechnology company, established to innovate and deliver products and services related to exosome technology for molecular and cell biology research and therapeutic purposes, particularly regenerative medicine and cancer treatment. EriVan Bio is focused on the development of a broad pipeline of novel and targeted biomolecules to address different unmet medical needs. EriVan Bio works mainly in the therapeutic and drug development field and on exosome-based diagnostics to develop exosome-based tests and assays for unmet medical needs. Moreover, there is a potential for exosomes to be used as targeted delivery vehicles of therapeutic molecules to cancer cells, for example, delivering a small interfering RNA specific for a particular oncogene expressed in a tumor cell. Research tools for exosome detection and isolation constitute another field of expertise and development.

EriVan Bio LLC Questions

The EriVan Bio LLC annual revenue was $4 million in 2026.

Steve Pomeroy is the Director Of Operations of EriVan Bio LLC.

1 people are employed at EriVan Bio LLC.

EriVan Bio LLC is based in Alachua, Florida.

The NAICS codes for EriVan Bio LLC are [541713, 5417, 54171, 541, 54].

The SIC codes for EriVan Bio LLC are [873, 87].

Top EriVan Bio LLC Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users